Tectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2 [Seeking Alpha]
Tectonic Therapeutic, Inc. (TECX)
Company Research
Source: Seeking Alpha
TX45's engineered Fc-relaxin fusion overcomes prior failures by extending half-life, enabling durable hemodynamic improvements in the CpcPH subgroup per robust phase 1b data. With a $253.8M cash balance, TECX is funded for phase 2; positive topline data in 2026 could unlock a $0.6B–$1.8B U.S. peak sales opportunity. I rate TECX a Buy for its binary, high-upside profile, solid early data, and potential for 2-3x returns if phase 2/3 data confirm efficacy. lenalir/iStock via Getty Images Tectonic Therapeutic ( TECX ) is reviving relaxin biology. Target indication is Group 2 Pulmonary Hypertension (PH) in the presence of Heart Failure with Preserved Ejection Fraction (HFpEF). They are trying to build commercial and clinical success out of a pathway
Show less
Read more
Impact Snapshot
Event Time:
TECX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECX alerts
High impacting Tectonic Therapeutic, Inc. news events
Weekly update
A roundup of the hottest topics
TECX
News
- Tectonic Therapeutic (TECX) was given a new $75.00 price target by Stifel Nicolaus.MarketBeat
- Tectonic Therapeutic to Participate in March Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Tectonic Therapeutic to Participate in March Investor ConferencesGlobeNewswire
- Tectonic Therapeutic GAAP EPS of -$1.03 beats by $0.08 [Seeking Alpha]Seeking Alpha
- Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
TECX
Earnings
- 11/6/25 - Beat
TECX
Sec Filings
- 4/3/26 - Form 4
- 4/3/26 - Form 4
- 4/3/26 - Form 3
- TECX's page on the SEC website